Mechanisms regulating prostaglandin H2 synthase-2 mRNA level in the amnion and chorion during pregnancy

Journal of Endocrinology

Volumn 188, Issue 3, 2006, Pages 603-610

  Johnson, Renée F ^b,c   Mitchell, Carolyn M ^c   Giles, Warwick B ^a,b,c   Bisits, Andrew ^a,b,c   Zakar, Tamas ^a,b,c  

^a JOHN HUNTER HOSPITAL   (Australia)

^b UNIVERSITY OF NEWCASTLE   (Australia)

^c HUNTER MEDICAL RESEARCH INSTITUTE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ISOENZYME; MESSENGER RNA; NUCLEAR RNA; PROSTAGLANDIN SYNTHASE; PROSTAGLANDIN SYNTHASE 2; UNCLASSIFIED DRUG;

AMNION; ANALYSIS OF VARIANCE; ARTICLE; AUSTRALIA; CHORION; ENZYME ACTIVITY; ENZYME REGULATION; ENZYME SYNTHESIS; FEMALE; FETUS MEMBRANE; GENE ACTIVITY; GENETIC TRANSCRIPTION; HUMAN; KRUSKAL WALLIS TEST; PATH ANALYSIS; PLACENTA; PREGNANCY; PRIORITY JOURNAL; PROSTAGLANDIN SYNTHESIS; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; REGULATORY MECHANISM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA PROCESSING; UPREGULATION;

AMNION; CHORION; CYCLOOXYGENASE 2; FEMALE; GENE EXPRESSION; HUMANS; LABOR, OBSTETRIC; PREGNANCY; PREGNANCY TRIMESTER, FIRST; PREGNANCY TRIMESTER, THIRD; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER;

EID: 33645231125     PISSN: 00220795     EISSN: None     Source Type: Journal    
DOI: 10.1677/joe.1.06488     Document Type: Article

References (29)

1. Challis JR, Patel FA & Pomini F 1999 Prostaglandin dehydrogenase and the initiation of labor. Journal of Perinatal Medicine 27 26-34.
2. Challis JRG, Matthews SG, Gibb W & Lye SJ 2000 Endocrine and paracrine regulation of birth at term and preterm. Endocrine Reviews 21 514-550.
3. Elferink CJ & Reiners JJ Jr. 1996 Quantitative RT-PCR on CYP1A1 heterogeneous nuclear RNA: a surrogate for the in vitro transcription run-on assay. Biotechniques 20 470-477.
4. Freed KA, Aitken MA, Brennecke SP & Rice GE 1995 Prostaglandin G/H synthase-1 messenger RNA relative abundance in human amnion, choriodecidua and placenta before, during and after spontaneous- onset labour at term. Gynecology and Obstetics Investigations 39 73-78.
5. Funk CD, Funk LB, Kennedy ME, Pong AS & Fitzgerald GA 1991 Human platelet/erythroleukemia cell prostaglandin G/H synthase: cDNA cloning, expression, and gene chromosomal assignment. FASEB Journal 5 2304-2312.
6. Germain AM, Smith J, Casey ML & MacDonald PC 1994 Human fetal membrane contribution to the prevention of parturition: uterotonin degradation. Journal of Clinical Endocrinology and Metabolism 78 463-470.
7. Hirsch E, Goldstein M, Filipovich Y & Wang H 2005 Placental expression of enzymes regulating prostaglandin synthesis and degradation. American Journal of Obstetrics and Gynecology 192 1836-1843.
8. Hirst JJ, Teixeira FJ, Zakar T & Olson DM 1995 Prostaglandin endoperoxide-H synthase-1 and -2 messenger ribonucleic acid levels in human amnion with spontaneous labor onset. Journal of Clinical Endocrinology and Metabolism 80 517-523.
9. Johnson RF, Mitchell CM, Giles WB, Walters WA & Zakar T 2002 The in vivo control of prostaglandin H synthase-2 messenger ribonucleic acid expression in the human amnion at parturition. Journal of Clinical Endocrinology and Metabolism 87 2816-2823.
10. Johnson RF, Mitchell CM, Giles WB, Walters WA & Zakar T 2003 The control of prostaglandin endoperoxide H-Synthase-2 expression in the human chorion laeve at term. Journal of the Society for Gynecological Investigations 10 222-230.
11. Johnson RF, Mitchell CM, Clifton V & Zakar T 2004 Regulation of 15-Hydroxyprostaglandin Dehydrogenase (PGDH) Gene activity, messenger ribonucleic acid processing, and protein abundance in the human chorion in late gestation and labor. Journal of Clinical Endocrinology and Metabolism 89 5639-5648.
12. Lala PK 1989 Similarities between immunoregulation in pregnancy and in malignancy: the role of prostaglandin E2. American Journal of Reproduction and Immunology 20 147-152.
13. Liggins GC & Wilson T 1989 Phospholipases in the control of human parturition. American Journal of Perinatology 6 153-158.
14. MacDonald PC & Casey ML 1993 The accumulation of prostaglandins (PG) in amniotic fluid is an aftereffect of labor and not indicative of a role for PGE2 or PGF2 alpha in the initiation of human parturition. Journal of Clinical Endocrinology and Metabolism 76 1332-1339.
15. Mijovic JE, Zakar T, Nairn TK & Olson DM 1997 Prostaglandin-endoperoxide H synthase-2 expression and activity increases with term labor in human chorion. American Journal of Physiology 272 E832-E840.
16. Mijovic JE, Zakar T, Nairn TK & Olson DM 1998 Prostaglandin endoperoxide H synthase (PGHS) activity and PGHS-1 and -2 messenger ribonucleic acid abundance in human chorion throughout gestation and with preterm labor. Journal of Clinical Endocrinology and Metabolism 83 1358-1367.
17. Mijovic JE, Zakar T, Angelova J & Olson DM 1999 Prostaglandin endoperoxide H synthase mRNA expression in the human amnion and decidua during pregnancy and in the amnion at preterm labour. Molecular Human Reproduction 5 182-187.
18. Mitchell BF & Powell WA 1984 Progesterone production by human fetal membranes: an in vitro incubation system for studying hormone production and metabolism. American Journal of Obstetics and Gynecology 148 303-309.
19. Norwitz ER, Schust DJ & Fisher SJ 2001 Implantation and the survival of early pregnancy. New England Journal of Medicine 345 1400-1408.
20. Powell WA, Mitchell BF & Challis JR 1986 Effects of steroids on progesterone output by explants of human chorion. Gynecology and Obstetics Investigations 22 64-72.
21. Rowe K 2002 The measurement of latent and composite variables from multiple items or indicators: Applications in performance indicator systems. In Background paper to keynote address presented at the RMIT Statistics Seminar Series, October 11, 2002, pp 1-23. Camberwell, Victoria, Australia: Australian Council for Educational Research; available at:
22. Sadovsky Y, Nelson DM, Muglia LJ, Gross GA, Harris KC, Koki A, Masferrer JL & Olson LM 2000 Effective diminution of amniotic prostaglandin production by selective inhibitors of cyclooxygenase type 2. American Journal of Obstetics and Gynecology 182 370-376.
23. Slater D, Berger L, Newton R, Moore G & Bennett P 1994 The relative abundance of type 1 to type 2 cyclo-oxygenase mRNA in human amnion at term. Biochemical and Biophysical Research Communications 198 304-308.
24. Slater D, Allport V & Bennett P 1998 Changes in the expression of the type-2 but not the type-1 cyclo- oxygenase enzyme in chorion-decidua with the onset of labour. British Journal of Obstetics and Gynaecology 105 745-748.
25. Slater D, Dennes W, Sawdy R, Allport V & Bennett P 1999 Expression of cyclo-oxygenase types-1 and -2 in human fetal membranes throughout pregnancy. Journal of Molecular Endocrinology 22 125-130.
26. Slater DM, Berger LC, Newton R, Moore GE & Bennett PR 1995 Expression of cyclooxygenase types 1 and in human fetal membranes at term. American Journal of Obstetics and Gynecology 172 77-82.
27. Smith WL, DeWitt DL & Garavito RM 2000 Cyclooxygenases: structural, cellular, and molecular biology. Annual Reviews in Biochemistry 69 145-182.
28. Teixeira FJ, Zakar T, Hirst JJ, Guo F, Sadowsky DW, Machin G, Demianczuk N, Resch B & Olson DM 1994 Prostaglandin endoperoxide-H synthase (PGHS) activity and immunoreactive PGHS-1 and PGHS-2 levels in human amnion throughout gestation, at term, and during labor. Journal of Clinical Endocrinology and Metabolism 78 1396-1402.
29. Trautman MS, Edwin SS, Collmer D, Dudley DJ, Simmons D & Mitchell MD 1996 Prostaglandin H synthase-2 in human gestational tissues: regulation in amnion. Placenta 17 239-245.